UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy

Circulation (New York, N.Y.), 2008-07, Vol.118 (2), p.e29-e35

2008

Volltextzugriff (PDF)

Evaluating research and impact: a bibliometric analysis of research by the NIH/NIAID HIV/AIDS clinical trials networks

PloS one, 2011-03, Vol.6 (3), p.e17428-e17428

2011

Volltextzugriff (PDF)

No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Term Results from ACTG A5001/ALLRT

Clinical infectious diseases, 2011-04, Vol.52 (7), p.929-940

2011

Volltextzugriff (PDF)

Infection control best practices in clinical research in resource-limited settings

Journal of acquired immune deficiency syndromes (1999), 2014-01, Vol.65 Suppl 1 (Supplement 1), p.S15-S18

2014

Volltextzugriff (PDF)

Construct validity and responsiveness of a health-related symptom index for persons either treated or monitored for anal high-grade squamous intraepithelial lesions (HSIL): AMC-A01/-A03

Quality of life research, 2023-08, Vol.32 (8), p.2293-2304

2023

Volltextzugriff (PDF)

Implementation of HIV-related clinical research in the international setting

Journal of acquired immune deficiency syndromes (1999), 2014-01, Vol.65 Suppl 1 (Supplement 1), p.S1-S2

2014

Volltextzugriff (PDF)

Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals

Journal of acquired immune deficiency syndromes (1999), 2012-11, Vol.61 (3), p.381-389

2012

Volltextzugriff (PDF)

Changes in metabolic syndrome status after initiation of antiretroviral therapy

Journal of acquired immune deficiency syndromes (1999), 2015-01, Vol.68 (1), p.73-80

2015

Volltextzugriff (PDF)

Ensuring participant safety and trial integrity with clinical trials oversight

Journal of acquired immune deficiency syndromes (1999), 2014-01, Vol.65 Suppl 1 (Supplement 1), p.S40-S43

2014

Volltextzugriff (PDF)

A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countries

BMC infectious diseases, 2016-06, Vol.16 (1), p.269-269, Article 269

2016

Volltextzugriff (PDF)

Substitution of Nevirapine because of Efavirenz Toxicity in AIDS Clinical Trials Group A5095

Clinical infectious diseases, 2010-03, Vol.50 (5), p.787-791

2010

Volltextzugriff (PDF)

Evidence for limited genetic compartmentalization of HIV-1 between lung and blood

PloS one, 2009-09, Vol.4 (9), p.e6949-e6949

2009

Volltextzugriff (PDF)

Controlling healthcare-associated infections in the international research setting

Journal of acquired immune deficiency syndromes (1999), 2013-04, Vol.62 (4), p.e115-e118

2013

Volltextzugriff (PDF)

Incidence of Non-AIDS-Defining Cancer in Antiretroviral Treatment-Naïve Subjects after Antiretroviral Treatment Initiation: An ACTG Longitudinal Linked Randomized Trials Analysis

Oncology, 2011-01, Vol.80 (1-2), p.42-49

2011

Volltextzugriff (PDF)

Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio

AIDS (London), 2007-01, Vol.21 (1), p.47-57

2007

Volltextzugriff (PDF)

Equal HIV-1 decay kinetics in HSV-2-infected and HSV-2-uninfected clinical trial participants treated with antiretroviral therapy

Journal of acquired immune deficiency syndromes (1999), 2012-05, Vol.60 (1), p.68-71

2012

Volltextzugriff (PDF)

Linguistic validation of the Spanish version of the Anal Cancer High-Grade squamous intraepithelial lesions outcomes Research Health-Related Symptom Index (A-HRSI): AMC-A04

Journal of patient-reported outcomes, 2022-10, Vol.6 (1), p.108-7, Article 108

2022

Volltextzugriff (PDF)

Factors associated with remaining on initial randomized efavirenz-containing regimens

AIDS (London), 2013-07, Vol.27 (12), p.1887-1897

2013

Volltextzugriff (PDF)

Assessing the challenges of multi-scope clinical research sites: an example from NIH HIV/AIDS clinical trials networks

Journal of evaluation in clinical practice, 2014-04, Vol.20 (2), p.149-157

2014

Volltextzugriff (PDF)

Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group

Clinical infectious diseases, 2000-11, Vol.31 (5), p.1216-1224

2000

Volltextzugriff (PDF)

Evaluating protocol lifecycle time intervals in HIV/AIDS clinical trials

Clinical trials (London, England), 2014-10, Vol.11 (5), p.553-559

2014

Volltextzugriff (PDF)

Modeling the dissemination and uptake of clinical trials results

Research evaluation, 2013-09, Vol.22 (3), p.179-186

2013

Volltextzugriff (PDF)

Reply to Gelinck and Burger

Clinical infectious diseases, 2010-08, Vol.51 (3), p.365-366

2010

Volltextzugriff (PDF)

A prospective study of hearing changes after beginning zidovudine or didanosine in HIV-1 treatment-naïve people

BMC infectious diseases, 2006-02, Vol.6 (1), p.28-28, Article 28

2006

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Englisch
(91)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy

Evaluating research and impact: a bibliometric analysis of research by the NIH/NIAID HIV/AIDS clinical trials networks

No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Term Results from ACTG A5001/ALLRT

Infection control best practices in clinical research in resource-limited settings

Construct validity and responsiveness of a health-related symptom index for persons either treated or monitored for anal high-grade squamous intraepithelial lesions (HSIL): AMC-A01/-A03

Implementation of HIV-related clinical research in the international setting

Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals

Changes in metabolic syndrome status after initiation of antiretroviral therapy

Ensuring participant safety and trial integrity with clinical trials oversight

A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countries

Substitution of Nevirapine because of Efavirenz Toxicity in AIDS Clinical Trials Group A5095

Evidence for limited genetic compartmentalization of HIV-1 between lung and blood

Controlling healthcare-associated infections in the international research setting

Incidence of Non-AIDS-Defining Cancer in Antiretroviral Treatment-Naïve Subjects after Antiretroviral Treatment Initiation: An ACTG Longitudinal Linked Randomized Trials Analysis

Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio

Equal HIV-1 decay kinetics in HSV-2-infected and HSV-2-uninfected clinical trial participants treated with antiretroviral therapy

Linguistic validation of the Spanish version of the Anal Cancer High-Grade squamous intraepithelial lesions outcomes Research Health-Related Symptom Index (A-HRSI): AMC-A04

Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer

Factors associated with remaining on initial randomized efavirenz-containing regimens

Assessing the challenges of multi-scope clinical research sites: an example from NIH HIV/AIDS clinical trials networks

Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group

Evaluating protocol lifecycle time intervals in HIV/AIDS clinical trials

Modeling the dissemination and uptake of clinical trials results

Reply to Gelinck and Burger

A prospective study of hearing changes after beginning zidovudine or didanosine in HIV-1 treatment-naïve people

Suchergebnisse filtern